StockData
SS Innovations International, Inc. logo

SS Innovations International, Inc. (SSII) stock analysis

SSIINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 8/3063% below fair value
$1.32−0.19 (-12.58%)

Close on Nov 12, 2026Market cap $264.51MP/E –Yield –

StockData Score

Prices as of Nov 12, 2026How the score works

Value2Growth2Performance2Health2Dividend0

Weak8 of 30 checks passed

SS Innovations International passes 8 of the 30 checks behind our score; 16 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
2/6
Growth
2/6
Past performance
2/6
Financial health
2/6
Dividend
0/6

What stands out

  • Margin of safety over 20%

    The price is 62.9% below fair value, more than the 20% cushion we look for.

  • Trading below fair value

    The share price of $1.32 is below our fair value estimate of $3.56.

  • Revenue growing 10%+ a year

    Revenue grew 209% a year over the last three fiscal years.

  • Low bankruptcy risk

    The Altman Z-score is 3.49; above 3 is the safe zone and below 1.8 the distress zone.

What to watch

  • Return on capital under 10%

    Return on invested capital was -20.9%, below the 10% that usually covers the cost of capital.

  • Interest not well covered

    Operating income covers interest expense -7.4 times; we look for at least 5.

  • P/B above the industry

    SS Innovations International's price-to-book of 4.95 is above the Surgical, Medical, and Dental Instruments and Supplies median of 3.41.

  • Gross margin slipping

    Gross margin was 47.6% over the last twelve months, against 48.1% a year earlier.

Valuation2/6

  • P/E against its history

    Not enough price and earnings history to compare.

  • P/E against the industry

    Needs positive earnings and enough profitable companies in the industry.

  • EV/EBITDA against its history

    Needs positive EBITDA and price history.

  • P/B above the industry

    SS Innovations International's price-to-book of 4.95 is above the Surgical, Medical, and Dental Instruments and Supplies median of 3.41.

  • Trading below fair value

    The share price of $1.32 is below our fair value estimate of $3.56.

  • Margin of safety over 20%

    The price is 62.9% below fair value, more than the 20% cushion we look for.

Growth2/6

  • Revenue growing 10%+ a year

    Revenue grew 209% a year over the last three fiscal years.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing faster than the industry

    Revenue grew 89.7% over the last twelve months; the Surgical, Medical, and Dental Instruments and Supplies median is 10.6%.

  • Company guidance

    No outlook found in earnings releases from the last twelve months.

  • Gross margin slipping

    Gross margin was 47.6% over the last twelve months, against 48.1% a year earlier.

Past performance2/6

  • Return on equity

    Needs positive equity and five years of results.

  • Return on capital under 10%

    Return on invested capital was -20.9%, below the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    SS Innovations International's return on equity of -26.1% is above the Surgical, Medical, and Dental Instruments and Supplies median of -30.2%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin above its 5-year average

    Net margin was -23.7% over the last twelve months, against a 5-year average of -175%.

  • Net margin below the industry

    SS Innovations International's net margin of -23.7% is below the Surgical, Medical, and Dental Instruments and Supplies median of -13.5%.

Financial health2/6

  • Debt level

    Needs debt and equity figures.

  • Debt trend

    Needs a balance sheet from five years ago with positive equity.

  • Debt coverage

    Needs operating cash flow.

  • Interest not well covered

    Operating income covers interest expense -7.4 times; we look for at least 5.

  • Short-term assets cover short-term debts

    Current assets are 2.24 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 3.49; above 3 is the safe zone and below 1.8 the distress zone.

Dividend0/6

  • No dividend

    SS Innovations International has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Fair value

How we estimate it

Our estimate per share

$3.56

The share price is 63% below this estimate.

20%+ below
Near fair value
20%+ above
$1.32Price$3.56Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/B12.0×37.8×3.4×$3.2050%
P/S15.0×49.0×2.7×$3.9250%
Fair value$3.56100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/B at month end
  • Own 5-year median 37.8
  • Surgical, Medical, and Dental Instruments and Supplies median 3.4

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

High risk

Average value traded per day
$159.85K
Value traded per 1% price move
$45.49K

Downside

High risk

Typical loss in a bad month
37.3%
Volatility (annualized)
85%
Sharpe ratio, 1 year
-1.00
Beta to the S&P 500 (5Y)
–

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2015 to 2025

Gross margin

46.0%

Operating margin

-19.3%

Net margin

-28.5%

See a number that looks wrong?